ADMA. Back to history area.ADMA. Back to history area.
Squeezed too low. High insider, high institional value.
0%
0%
0%
0%
0%
About ADMA Biologics Inc
Sector
Health Technology
Industry
Biotechnology
CEO
Adam S. Grossman
Website
admabiologics.com
Headquarters
Ramsey
Employees
617
Founded
2004
ISIN
US0008991046
ADMA Biologics, Inc. operates as a biopharmaceutical company, which is engaged in manufacturing, marketing, and developing specialty plasma-derived biologics. The firm operates through the following business segments: ADMA BioManufacturing, Plasma Collection Center, and Corporate. The ADMA BioManufacturing segment consists of immune globulin manufacturing and development operations. The Plasma Collection Center consists of source plasma collection facilities. The Corporate segment includes general and administrative overhead expenses. The company was founded by Adam S. Grossman and Jerrold B. Grossman on June 24, 2004 and is headquartered in Ramsey, NJ.
ADMA BIOLOGICS Stock Chart Fibonacci Analysis 050423Trading Idea
1) Find a FIBO slingshot
2) Check FIBO 61.80% level
3) Entry Point > 3.38/61.80%
AdmaBiologics stock analysisThere might be a " head and shoulders " pattern.
Otherwise, buying may be possible when the stochastic indicator or MACD indicator forms a golden cross .
ADMA Break OutThe MACD recentlty crossed and both the short and long term force index turned positive.
The 8/11 candle broke above resistance and closed there, taking out the 1 Fibonacci level while doing so. Despite the long upper wick on 8/11, the 8/12 candle closed above the prior close and also closed above
Relative Strength in Biotech - ADMA (1/5) To highlight my point in the previous $VIVO post, here are 5 other charts in the Biotech sector that have shown relative strength lately. Don't get me wrong, the market is still on a downtrend, but should we reverse and start a new uptrend, this sector may potentially be the next one to lead a
Long
Preferred Stock
The Company is currently authorized to issue up to 10 million shares of preferred stock, $0.0001, par value per share. There were no shares of preferred stock outstanding at September 30, 2021 and December 31, 2020.
Common Stock
As of September 30, 2021 and December 31, 2020, the
2024 long SEC.gov The Company believes that a debt refinancing and expansion of its current debt facility, combined with the proceeds received from the foregoing public offering further discussed in Note 14, will be sufficient to fund its operations into the first quarter of 2024, at which time the Company be
ADMA - OBVIOUS BUY DUHHHAll,
Just look at larger timeframes and price targets + last two EPS. I'm going in with 5% stop loss here. No reason not to. Undervalued, float is mediocre nothing great, but absolutely worth a stab here.
ADMA (ADMA BIOLOGICS INC) BUYHi there. Price is forming a big reversal pattern to change its direction. Also is close to 0 value which is a very good sign. Watch strong price action at the current levels for buy.
ADMA LongHook Reversal
Trendline break
WR% crossed -80
Entry 1.5
Stop 1.3
Target 2.4
Risk management is much more important than a good entry point.
The max Risk of each plan should be less than 1% of an account.
I am not a PRO trader. I trade option to test my trading plan with small cost.
I created
See all ideas
This info isn't a recommendation for what you should personally do, so please don't take the data as investment advice. As with any trade, always look first, then leap. Read more in the Terms of Use.
